EUVIMEDScopri EUVIMED
Crossref

Pharmacokinetics of a New Neuroprotector — Indenoquinoxalinone Derivative after Intravenous Administration in Rabbits and Rats

E A Yanovskaya, G A Frelikh, A P Lakeev, G A Chernysheva, V I Smol'yakova, A R Kovrizhina

Bulletin of Experimental Biology and Medicine · 2023

DOI: 10.1007/s10517-023-05943-7 ↗

At a glance

Journal article in Bulletin of Experimental Biology and Medicine, 2023. Written by E A Yanovskaya and 5 co-authors. Institution: E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center, Russian Academy of Sciences, Tom…. Major MEDLINE topics: Liver. Cited 1 times so far (Crossref); 11 references.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

The specific JNK inhibitor and NO donor 11H-indeno[1,2-b]quinoxalin-11-one oxime (IQ-1) demonstrated pronounced neuroprotective properties in an in vivo model of ischemic stroke in rats. The pharmacokinetic behavior of IQ-1 was studied in two animal species (rats, rabbits) after intravenous administration in a dose of 1 mg/kg. IQ-1 concentrations in venous blood plasma were measured by the liquid chromatography-tandem mass spectrometry method. The pharmacokinetics of IQ-1 was adequately described by the two-compartmental model. The calculated C0 for IQ-1 in rabbit and rat plasma were 2239.83±1229.55 and 1552.50±182.23 ng/ml, respectively. Two animal species are characterized by extensive tissue distribution of IQ-1 (Vss exceeded the total body water in rabbits and rats by 3.6 and 5.6 times, respectively) and high clearance values (88-94% of hepatic blood flow).

Subjects

MeSH terms (MEDLINE)

LiverRatsRabbitsAnimalsInfusions, IntravenousTissue DistributionKineticsInjections, IntravenousAdministration, Intravenous

Author keywords

11H-indeno[1,2-b]quinoxalin-11-one oximeHPLCJNK inhibitorneuroprotectorpharmacokinetics

Authors and institutions

  • E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia. elena.yanovskaya@pharmso.ru.
  • E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia.
  • National Research Tomsk Polytechnic University, Tomsk, Russia.

Cite

APA

Yanovskaya, E. A., Frelikh, G. A., Lakeev, A. P., Chernysheva, G. A., Smol'yakova, V. I., & Kovrizhina, A. R. (2023). Pharmacokinetics of a New Neuroprotector — Indenoquinoxalinone Derivative after Intravenous Administration in Rabbits and Rats. Bulletin of Experimental Biology and Medicine. https://doi.org/10.1007/s10517-023-05943-7

Vancouver

Yanovskaya EA, Frelikh GA, Lakeev AP, Chernysheva GA, Smol'yakova VI, Kovrizhina AR. Pharmacokinetics of a New Neuroprotector — Indenoquinoxalinone Derivative after Intravenous Administration in Rabbits and Rats. Bulletin of Experimental Biology and Medicine. 2023. doi:10.1007/s10517-023-05943-7

BibTeX
@article{Yanovskaya2023,
  author = {Yanovskaya, E A and Frelikh, G A and Lakeev, A P and Chernysheva, G A and Smol'yakova, V I and Kovrizhina, A R},
  title = {Pharmacokinetics of a New Neuroprotector — Indenoquinoxalinone Derivative after Intravenous Administration in Rabbits and Rats},
  journal = {Bulletin of Experimental Biology and Medicine},
  year = {2023},
  doi = {10.1007/s10517-023-05943-7}
}
Start for free →